Health Care/Hospital

Ascletis Announces Poster Presentations at AASLD Annual Meeting 2023 Including a Late-Breaking Abstract of Interim Results from Phase IIb Expansion Cohort of ASC22 for Functional Cure of CHB

HANGZHOU and SHAOXING, China, Nov. 13, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces late-breaking abstract poster presentation of interim results from Phase IIb expansion cohort of ASC22 (Envafolimab) for functional cure of chronic hepatitis B (CHB), and abst...

2023-11-13 08:10 1892

PillWork Strengthens Global Ties Ahead of 2023 Launch with Strategic Partnerships

SEOUL, South Korea, Nov. 12, 2023 /PRNewswire/ -- PillWork, emerging as a pioneer in holistic wellness, is meticulously preparing for its anticipated launch at the end of 2023. As part of this build-up, PillWork has gained a place in the AWS Global Collaboration Program, ensuring top-tier app fu...

2023-11-13 08:00 1538

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center inSouth Korea. Colorectal cancer (CRC) is o...

2023-11-13 08:00 2284

First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591

MELBOURNE, Australia, Nov. 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company's Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen (PSMA) targeting radio...

2023-11-13 07:38 1207

Gillette & Braun sign Major Partnership with Movember

SYDNEY, Nov. 13, 2023 /PRNewswire/ -- In Australia, one in five men will be diagnosed with prostate cancer in their lifetime. One man globally dies by suicide every minute. Testicular cancer is the most common cancer among younger men. This November, Procter & Gamble's leading grooming brands Gi...

2023-11-13 05:30 1830

Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA

LEXINGTON, Mass., Nov. 11, 2023 /PRNewswire/ -- Fapon, a global leading life sciences organization, is thrilled to announce the grand opening of its US-based Research and Development (R&D) Center, strategically located in Lexington, Massachusetts. This Center represents Fapon's unwavering commitme...

2023-11-11 20:36 2674

SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York

One Retrospective Cohort, One Prospective Cohort, in Total of ~2,400 Cancer Patients and Non-cancer Individuals Demonstrate the Performance of SeekInCare Test to Detect Multiple Cancer Types and Predict Tissue of Origin of Cancers The Achievement of 65.5% Sensitivity at 97.9% Specificity in the ...

2023-11-10 21:00 1800

Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability

Company attributes B+ rating to progress related to its Human Rights Management Declaration, eco-friendly shipping box and the establishment of an internal ESG Committee SEOUL, South Korea, Nov. 10, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total so...

2023-11-10 20:00 3426

Shaping Global Policy: IFPA's Psoriatic Disease Response Index in the Western Pacific

STOCKHOLM, Nov. 10, 2023 /PRNewswire/ -- Psoriatic disease, recognized as a serious noncommunicable disease by the World Health Organization (WHO), impacts millions worldwide. A pioneering advocacy tool, the Psoriatic Disease Response Index, has emerged to facilitate a vital policy discussion, dr...

2023-11-10 19:18 3474

Brinc Hosts Successful Asia Health Innovation Summit 2023, Fostering Greater Ideations and Collaborations in the Healthcare Sector

HONG KONG, Nov. 10, 2023 /PRNewswire/ -- The Asia Health Innovation Summit 2023 , hosted by global venture accelerator Brinc as part of the StartmeupHK Festival curated by InvestHK, attracted an online audience of over 1,000 anda ful...

2023-11-10 18:43 2099

Lecheng, MSD vow to deepen medical cooperation

BEIJING, Nov. 10, 2023 /PRNewswire/ -- A news report from chinadaily.com.cn: MSD (Hainan) Innovative Medical Co Ltd is launched on Nov 6 during this year's CIIE. [Photo provided to chinadaily.com.cn] During the 6th China Int...

2023-11-10 18:03 2228

So-Young to Report Third Quarter 2023 Financial Results on November 20, 2023

BEIJING, Nov. 10, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its finan...

2023-11-10 18:00 1328

H2U Secures Strategic Investment from InnoTherapy as Recognition from Seoul Clinical Laboratories (SCL)

H2U platform enters the South Korean healthcare sector, driving AI-powered data analytics to expand their digital health offerings TAIPEI, Nov. 10, 2023 /PRNewswire/ -- H2U, Taiwan's premier digital health brand, proudly announced another successful round of funding this year after receiving rec...

2023-11-10 17:48 2342

FEBICO actively seeking business partners in United States, introduces "High- Spermidine" chlorella health supplements to satisfy U.S. market

TAIPEI, Nov. 10, 2023 /PRNewswire/ -- FEBICO is Asia's largest organic microalgae producer and has been distributed to over 60 countries since 1990. Today, FEBICO becomes algae tech pioneer and visioner to bring the power of microalgae to the next level. C...

2023-11-10 17:08 1090

TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert

SAN FRANCISCO, Nov. 10, 2023 /PRNewswire/ -- On October 26, 2023, SyMap Medical invited ProfessorFelix Mahfoud, Vice-Chair of the Working Group Interventional Hypertension Treatment of the European Society of Hypertension (ESH) and a distinguished authority in the renal denervation (RDN) field, t...

2023-11-10 16:46 1184

Zhejiang Pan'an: Gathering of Medicine Merchants for Development, Fragrance of Medicinal Herbs Attracts Visitors

JINHUA, China, Nov. 10, 2023 /PRNewswire/ -- From November 9th to 11th, the 2023 Zhejiang Province Traditional Chinese Medicinal Materials Expo and the 16th Pan'an Traditional Chinese Medicinal Materials Expo were held in Pan'an County, Jinhua City,Zhejiang Province. Experts from the traditional ...

2023-11-10 15:16 1496

GC Genome Enters License Agreement with MP Group

- Collaboration includes the transfer of GC Genome's essential wet lab know-how for SNP genotyping service. YONGIN, South Korea, Nov. 10, 2023 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it has entered into a collaboration and exclusive license agre...

2023-11-10 13:00 1546

Morinaga Milk Industry Group (ELOVI Vietnam) Introduces Two New Products in Collaboration with WinCommerce

HANOI, Vietnam, Nov. 10, 2023 /PRNewswire/ -- Morinaga Milk Industry Group (ELOVI Vietnam), one of the world's leading dairy and dairy product corporations headquartered inJapan, is partnering with WinCommerce General Trading Services Joint Stock Company to unveil two premium products, Climeal N...

2023-11-10 12:09 2223

Ministry of Oceans and Fisheries, KOREA FISHERIES ASSOCIATION, and CUCKOO Collaborate to Introduce 'K-FISH' to Malaysia

SEOUL, South Korea, Nov. 10, 2023 /PRNewswire/ -- The South Korean government agency, the Ministry of Oceans and Fisheries, and the KOREA FISHERIES ASSOCIATION have announced a collaboration with CUCKOO INTERNATIONAL to launch the 'K·FISH POP UP' event at the CUCKOO Brand Gallery in Kuching, Mala...

2023-11-10 08:00 2309

MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results

SHENZHEN, China, Nov. 9, 2023 /PRNewswire/ -- On November 9, 2023, ImmVira announced the successful completion of Phase I clinical study conducted on late-stage patients with various tumor types for our intravenous oncolytic product, MVR-T3011 IV, inthe United States. This milestone was marked by...

2023-11-10 08:00 1595
1 ... 68697071727374 ... 807